The provided text is a tutorial on using screencast software for Mac and Windows and contains no clinical trial data.
Does a fixed-dose triple-combination therapy improve blood pressure control in adults with arterial hypertension?
This is a protocol for a randomized clinical trial evaluating a fixed-dose triple-combination therapy for the initial treatment of hypertension.
Introduction Complications from arterial hypertension account for an estimated 18 deaths per minute worldwide, establishing it as the second leading risk factor for global mortality. Between 1990 and 2019, the number of adults with arterial hypertension doubled from 650 million to 1.3 billion. Of these, only 54% are diagnosed, 42% are treated, and a mere 21% of those treated achieve adequate blood pressure (BP) control. Although effective BP control often requires the use of multiple drugs, monotherapy remains a predominant ...
Orlow et al. (Thu,) reported a other. The provided text is a tutorial on using screencast software for Mac and Windows and contains no clinical trial data.